🇺🇸 FDA
Patent

US 8114590

Diagnosis and treatment of chronic lymphocytic leukemia (CLL)

granted A61PA61P35/02

Quick answer

US patent 8114590 (Diagnosis and treatment of chronic lymphocytic leukemia (CLL)) held by The Regents of the University of California expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P35/02